The lack of antitumor efficacy of PMG5 in unvaccinated mice indicates that the efficacy of the Ad5-TRP2/PMG5 treatment was not due to tumor cell death directly induced by PMG5 but possibly an immunological effect relating to the innate arm of the immune system that creates a favorable environment for CTL activity. The gene discussed is DCT; the disease is neoplasm.